Prof David Jackson
Honorary (Professorial Fellow)
Department of Microbiology and Immunology
318 Scholarly works
59 Projects
HIGHLIGHTS
2025
Journal article
Bovine tracheal organoids for studying Mycoplasma bovis respiratory infections.
DOI: 10.1016/j.vetmic.2024.1103402025
Journal article
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4 and CD8 T-cell responses and neutralizing antibody induction
DOI: 10.1128/jvi.02290-242023
Journal article
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
DOI: 10.1016/j.ebiom.2023.1048782023
Journal article
Development of Matrix-Embedded Bovine Tracheal Organoids to Study the Innate Immune Response against Bovine Respiratory Disease
DOI: 10.3390/organoids20200072021
Research Grant
Accelerated Phase I Trial of Targeted and Tunable SARS-Cov-2 Spike Protein Receptor Binding Domain Recombinant Protein and mRNA Vaccines
2020
Research Grant
A Safe, Effective, and Rapidly Tuneable SARS-CoV-2 Vaccine
2020
Research Grant
Harnessing Innate Immunity to Mitigate Bovine Respiratory Disease
RECENT SCHOLARLY WORKS
2023
Journal article
377. Phase I trial of two novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as 4th dose boosters
DOI: 10.1093/ofid/ofad500.4472022
Journal article
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
DOI: 10.1371/journal.ppat.10108912022
Journal article
Abstract 3502: AXA-042 - a novel systemic TLR2/6 agonist for anti-tumor therapy
DOI: 10.1158/1538-7445.am2022-35022022
Conference Proceedings
AXA-042-a novel systemic TLR2/6 agonist for anti-tumor therapy
2022
Journal article
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection
DOI: 10.3390/ijms230208352022
Journal article
Nonhuman primate models for evaluation of SARS-CoV-2 vaccines
DOI: 10.1080/14760584.2022.2071264
RECENT PROJECTS
2020
Research contracts (non-grants)
Determine the Single and Multiple-Dose Exposure on Cytokine Profile, and Post Exposure Efficacy of INNA-X in Influenza-Challenged Mice
2015
Research contracts (non-grants)
Lead Selection for Respiratory Program